Nouf Alfadel

Saudi Food and Drug Authority (SFDA), Saudi Arabia

Poster(s):

• (206) Evaluation of The Safety Information in "Fertility, Pregnancy and Lactation" Section of Product Information in Saudi Arabia
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (244) Flaxseed Interaction with Warfarin and Clopidogrel and The Potential Risk of Bleeding
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (317) Ginkgo Biloba Interaction with Non-Steroidal Anti-Inflammatory Drugs and The Potential Risk of Bleeding
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (194) Optic Neuritis Associated with PD-1 /PD-L1 Checkpoint Inhibitors: Case Series Utilizing the WHO Global Database of Individual Case Safety Reports (ICSRs)
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (270) Pfizer-BioNTech COVID-19 Vaccine and The Potential Risk of Hypoesthesia: Analysis of The Global and Local Individual Case Safety Reports
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (173) Teriparatide and Potential Risk of Multiple Myeloma
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (9) Traceability of Insulin Glargine's Innovator and Its Biosimilar Products Adverse Drug Events Reports in Saudi Arabia
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST